NO2017043I2 - Nomegestrolacetat + fritt eller esterifisert østradiol - forlenget SPC - Google Patents

Nomegestrolacetat + fritt eller esterifisert østradiol - forlenget SPC

Info

Publication number: NO2017043I2
Authority: NO; Norway
Prior art keywords: spc; prolonged; free; nomegestrol acetate; esterified estradiol
Prior art date: 1996-10-08

Application number

NO2017043C

Other languages

English (en)

Other versions

NO2017043I1 (no

Original Assignee

Laboratoire Theramex

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-10-08

Filing date

2017-08-08

Publication date

2019-01-25

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9496456&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO2017043(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2017-08-08 Application filed by Laboratoire Theramex filed Critical Laboratoire Theramex

2017-08-08 Publication of NO2017043I1 publication Critical patent/NO2017043I1/no

2019-01-25 Publication of NO2017043I2 publication Critical patent/NO2017043I2/no

Links

VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 title 1
229960005309 estradiol Drugs 0.000 title 1
229930182833 estradiol Natural products 0.000 title 1
229960004190 nomegestrol acetate Drugs 0.000 title 1
IIVBFTNIGYRNQY-YQLZSBIMSA-N nomegestrol acetate Chemical compound C1=C(C)C2=CC(=O)CC[C@@H]2[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(C)=O)(OC(=O)C)[C@@]1(C)CC2 IIVBFTNIGYRNQY-YQLZSBIMSA-N 0.000 title 1
230000002035 prolonged effect Effects 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/26—Androgens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/811—Drug, bio-affecting and body treating compositions involving sex selection or contraception

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Diabetes (AREA)
Gynecology & Obstetrics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Orthopedics, Nursing, And Contraception (AREA)

NO2017043C 1996-10-08 2017-08-08 Nomegestrolacetat + fritt eller esterifisert østradiol - forlenget SPC NO2017043I2 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR9612239A FR2754179B1 (fr)	1996-10-08	1996-10-08	Nouvelle composition hormononale et son utilisation
PCT/FR1997/001792 WO1998015279A1 (fr)	1996-10-08	1997-10-08	Composition hormonale constituee d'un compose estrogene et d'un compose progestatif

Publications (2)

Publication Number	Publication Date
NO2017043I1 NO2017043I1 (no)	2017-08-08
NO2017043I2 true NO2017043I2 (no)	2019-01-25

Family

ID=9496456

Family Applications (3)

Application Number	Title	Priority Date	Filing Date
NO19991593A NO324357B1 (no)	1996-10-08	1999-03-31	Anvendelse av et ostroprogestagenhormonpreparat ved fremstillingen av et medikament for behandling av ostrogenforstyrrelser og osteoporose hos postmenopausale kvinner, samt anvendelse av et farmasoytisk preparat ved fremstilling av et medikament for a stoppe ovulasjon
NO2012002C NO2012002I2 (no)	1996-10-08	2012-01-24	Nomegestrolacetat + fritt eller esterifisert østradiol
NO2017043C NO2017043I2 (no)	1996-10-08	2017-08-08	Nomegestrolacetat + fritt eller esterifisert østradiol - forlenget SPC

Family Applications Before (2)

Application Number	Title	Priority Date	Filing Date
NO19991593A NO324357B1 (no)	1996-10-08	1999-03-31	Anvendelse av et ostroprogestagenhormonpreparat ved fremstillingen av et medikament for behandling av ostrogenforstyrrelser og osteoporose hos postmenopausale kvinner, samt anvendelse av et farmasoytisk preparat ved fremstilling av et medikament for a stoppe ovulasjon
NO2012002C NO2012002I2 (no)	1996-10-08	2012-01-24	Nomegestrolacetat + fritt eller esterifisert østradiol

Country Status (38)

Country	Link
US (4)	US6831073B1 (no)
EP (2)	EP1334725B1 (no)
JP (1)	JP4883542B2 (no)
KR (2)	KR20000048981A (no)
CN (3)	CN1239893A (no)
AP (1)	AP1171A (no)
AR (2)	AR009113A1 (no)
AT (2)	ATE353652T1 (no)
AU (1)	AU745571B2 (no)
BR (1)	BR9712274A (no)
CA (1)	CA2268358C (no)
CL (1)	CL2011000017A1 (no)
CZ (1)	CZ298402B6 (no)
DE (3)	DE69721314T2 (no)
DK (2)	DK0956022T3 (no)
DZ (1)	DZ2327A1 (no)
ES (2)	ES2282539T3 (no)
FR (2)	FR2754179B1 (no)
HK (1)	HK1210708A1 (no)
HU (2)	HU227450B1 (no)
ID (1)	ID21569A (no)
IL (1)	IL129194A (no)
LU (1)	LU91932I2 (no)
MA (1)	MA24370A1 (no)
MY (1)	MY128482A (no)
NO (3)	NO324357B1 (no)
NZ (1)	NZ334876A (no)
OA (1)	OA11033A (no)
PL (1)	PL192979B1 (no)
PT (2)	PT956022E (no)
RU (1)	RU2274450C2 (no)
SK (2)	SK285455B6 (no)
TN (1)	TNSN97164A1 (no)
TR (1)	TR199900764T2 (no)
TW (1)	TW491704B (no)
WO (1)	WO1998015279A1 (no)
YU (1)	YU18099A (no)
ZA (1)	ZA979011B (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE4344462C2 (de)	1993-12-22	1996-02-01	Schering Ag	Zusammensetzung für die Empfängnisverhütung
DE19549264A1 (de) *	1995-12-23	1997-06-26	Schering Ag	Verfahren und Kit zur Kontrazeption
FR2754179B1 (fr)	1996-10-08	1998-12-24	Theramex	Nouvelle composition hormononale et son utilisation
WO2001030355A1 (fr) *	1999-10-25	2001-05-03	Laboratoire Theramex	Medicament contraceptif a base d'un progestatif et d'un estrogene et son mode de preparation
WO2001030356A1 (fr) *	1999-10-25	2001-05-03	Laboratoire Theramex	Composition hormonale a base d'un progestatif et d'un estrogene et son utilisation
FR2814074B1 (fr) *	2000-09-15	2003-03-07	Theramex	Nouvelles compositions estro-progestatives topiques a effet systemique
FR2823976A1 (fr) *	2001-04-25	2002-10-31	Theramex	Nouvelle composition hormonale et son utilisation
GT200500315A (es) *	2004-11-02	2006-06-06		Formas de dosificacion oral solidas que contienen una dosis baja de estradiol
PE20081895A1 (es)	2007-03-26	2009-01-26	Theramex	Regimen anticonceptivo oral
RU2332219C1 (ru) *	2007-03-30	2008-08-27	Государственное образовательное учреждение высшего профессионального образования "БАШКИРСКИЙ ГОСУДАРСТВЕННЫЙ МЕДИЦИНСКИЙ УНИВЕРСИТЕТ Федерального Агентства по здравоохранению и социальному развитию" (ГОУ ВПО БГМУ РОСЗДРАВА)	Средство для модуляции плотности н2-гистаминовых рецепторов сердца при менопаузе
US20080293683A1 (en) *	2007-05-24	2008-11-27	University Of Kansas Medical Center	Hormone Replacement Therapy
TW200930343A (en) *	2007-09-21	2009-07-16	Organon Nv	Drug delivery system
WO2015086489A1 (en)	2013-12-11	2015-06-18	Merck Sharp & Dohme B.V.	Drug delivery system for delivery of anti-virals
US10413504B2 (en)	2013-12-11	2019-09-17	Merck Sharp & Dohme Corp.	Intravaginal ring drug delivery system
DE21794983T1 (de) *	2020-10-16	2022-11-17	Theramex HQ UK Limited	Verwendung von kombinierten oralen empfängnisverhütungsmitteln mit nomegestrolacetat und estradiol
KR102744791B1 (ko)	2022-07-05	2024-12-19	주식회사 이음정보	소멸특허 관리 및 특허거래 시스템

Family Cites Families (47)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3271392A (en) *	1965-09-14	1966-09-06	American Home Prod	17alpha-[3'-furyl]-estrogens
US4390531A (en)	1981-08-10	1983-06-28	Syntex Pharmaceuticals International Ltd.	Method of contraception using peak progestogen dosage
US4921843A (en)	1988-10-20	1990-05-01	Pasquale Samuel A	Contraception system and method
US4826831A (en)	1983-08-05	1989-05-02	Pre Jay Holdings Limited	Method of hormonal treatment for menopausal or post-menopausal disorders involving continuous administration of progestogens and estrogens
US4628051A (en) *	1983-09-26	1986-12-09	Ortho Pharmaceutical Corporation	Triphasic oral contraceptive
JPS61243059A (ja) *	1985-04-19	1986-10-29	Konishi Kagaku Kogyo Kk	高純度４，４′−ジヒドロキシジフエニルスルホンの製造法
ZA87332B (en)	1986-02-27	1987-08-26	Warner Lambert Co	Compositions containing fixed combinations
US5208225A (en) *	1986-02-27	1993-05-04	Warner-Lambert Company	Compositions containing fixed combinations
US5145682A (en) *	1986-05-30	1992-09-08	Rutgers, The State University Of New Jersey	Transdermal absorption dosage unit for postmenopausal syndrome treatment and process for administration
IE61236B1 (en)	1986-07-15	1994-10-19	American Home Prod	Combination dosage form for pre-menopausal women
US5256421A (en) *	1987-09-24	1993-10-26	Jencap Research Ltd.	Hormone preparation and method
US5276022A (en) *	1987-09-24	1994-01-04	Jencap Research Ltd.	Hormone preparation and method
CA1332227C (en)	1987-09-24	1994-10-04	Robert F. Casper	Oral contraceptive formulation
DE3888269T2 (de) *	1987-09-24	1994-07-07	Jencap Research Ltd	Hormon-Zusammensetzung und -Anwendung.
US5108995A (en) *	1987-09-24	1992-04-28	Jencap Research Ltd.	Hormone preparation and method
HUT52382A (en)	1988-03-14	1990-07-28	Sandoz Ag	Process for producing pharmaceutical compositions comprising as active ingredient unsubstituted progestin in 19-position and estrogen in the given case
IE71203B1 (en)	1990-12-13	1997-02-12	Akzo Nv	Low estrogen oral contraceptives
IE62665B1 (en)	1990-12-17	1995-02-22	Akzo Nv	Contraceptive regimen
FR2695826B1 (fr) *	1992-09-21	1995-01-06	Theramex	Nouvelles compositions pharmaceutiques à base de dérivés de nomégestrol et leurs procédés d'obtention.
US6150343A (en)	1993-06-30	2000-11-21	University Of Pittsburgh	Camptothecin analogs and methods of preparation thereof
US5554601A (en) *	1993-11-05	1996-09-10	University Of Florida	Methods for neuroprotection
DE4344462C2 (de) *	1993-12-22	1996-02-01	Schering Ag	Zusammensetzung für die Empfängnisverhütung
US5552394A (en) *	1994-07-22	1996-09-03	The Medical College Of Hampton Roads	Low dose oral contraceptives with less breakthrough bleeding and sustained efficacy
US6613757B1 (en)	1994-09-22	2003-09-02	Board Of Regents, The University Of Texas System	Combination of prostacyclin with an estrogen or progestin for the prevention and treatment of atherosclerotic vascular disease including preeclampsia and for the treatment of hypertension, and for hormone replacement therapy
SE9403389D0 (sv)	1994-10-06	1994-10-06	Astra Ab	Pharmaceutical composition containing derivattves of sex hormones
FR2737411B1 (fr) *	1995-08-01	1997-10-17	Theramex	Nouveaux medicaments hormonaux et leur utilisation pour la correction des carences estrogeniques
DE19540253C2 (de)	1995-10-28	1998-06-04	Jenapharm Gmbh	Mehrphasenpräparat zur Kontrazeption auf der Basis natürlicher Estrogene
DE19549264A1 (de)	1995-12-23	1997-06-26	Schering Ag	Verfahren und Kit zur Kontrazeption
WO1997041871A1 (en)	1996-05-08	1997-11-13	American Home Products Corporation	Oral contraceptive
AU2815897A (en)	1996-05-08	1997-11-26	American Home Products Corporation	Oral contraceptive
AU2926897A (en)	1996-05-08	1997-11-26	American Home Products Corporation	Oral contraceptive
WO1997041872A1 (en)	1996-05-08	1997-11-13	American Home Products Corporation	Oral contraceptive
AU2926797A (en)	1996-05-08	1997-11-26	American Home Products Corporation	Oral contraceptive
DE69724796T2 (de)	1996-07-26	2004-07-01	Wyeth	Biphasische orale verhuetungsmethode und kit die eine kombination von progestin und eines oestrogens enthalten
CN1119999C (zh)	1996-07-26	2003-09-03	惠氏公司	口服避孕药
WO1998004246A2 (en)	1996-07-26	1998-02-05	American Home Prod	Triphasic contraceptive method and kit comprising a combination of a progestin and estrogen
US5888543A (en) *	1996-07-26	1999-03-30	American Home Products Corporation	Oral contraceptives
WO1998004266A1 (en)	1996-07-26	1998-02-05	American Home Products Corporation	Oral contraceptive
WO1998004267A1 (en)	1996-07-26	1998-02-05	American Home Products Corporation	Progestin/estrogen oral contraceptive
WO2001030355A1 (fr)	1999-10-25	2001-05-03	Laboratoire Theramex	Medicament contraceptif a base d'un progestatif et d'un estrogene et son mode de preparation
FR2754179B1 (fr)	1996-10-08	1998-12-24	Theramex	Nouvelle composition hormononale et son utilisation
DE19705229C2 (de)	1997-02-12	1999-04-15	Hesch Rolf Dieter Prof Dr Med	Verwendung von drei Hormonkomponenten zur hormonalen Kontrazeption zur Behandlung und/oder Prophylaxe von Tumoren der Brustdrüsen
US5898032A (en)	1997-06-23	1999-04-27	Medical College Of Hampton Roads	Ultra low dose oral contraceptives with less menstrual bleeding and sustained efficacy
DK1007052T3 (da)	1997-08-27	2005-01-31	Ortho Mcneil Pharm Inc	Kombinationer af endometrisk skånende progesteroner og endometrisk atrofiserende progesteroner med östrogener ved oral svangerskabs-forebyggelse
DE19739916C2 (de) *	1997-09-11	2001-09-13	Hesch Rolf Dieter	Verwendung einer Kombination aus einem Gestagen und einem Estrogen zur kontinuierlichen Ovulationshemmung und ggf. gleichzeitigen Behandlung und/oder Prophylaxe von Tumoren der Brustdrüsen
AU759925B2 (en)	1997-09-12	2003-05-01	Wyeth	Oral contraceptive preparation having a first phase comprising progestin/estrogen and a second phase comprising progestin
WO2001030356A1 (fr)	1999-10-25	2001-05-03	Laboratoire Theramex	Composition hormonale a base d'un progestatif et d'un estrogene et son utilisation

1996
- 1996-10-08 FR FR9612239A patent/FR2754179B1/fr not_active Expired - Fee Related
1997
- 1997-10-07 TN TNTNSN97164A patent/TNSN97164A1/fr unknown
- 1997-10-08 ZA ZA9709011A patent/ZA979011B/xx unknown
- 1997-10-08 YU YU18099A patent/YU18099A/sh unknown
- 1997-10-08 HU HU9904508A patent/HU227450B1/hu active Protection Beyond IP Right Term
- 1997-10-08 ES ES03008979T patent/ES2282539T3/es not_active Expired - Lifetime
- 1997-10-08 DK DK97944940T patent/DK0956022T3/da active
- 1997-10-08 MY MYPI97004717A patent/MY128482A/en unknown
- 1997-10-08 EP EP03008979A patent/EP1334725B1/fr not_active Expired - Lifetime
- 1997-10-08 AP APAP/P/1999/001500A patent/AP1171A/en active
- 1997-10-08 RU RU2003107072/15A patent/RU2274450C2/ru active
- 1997-10-08 DE DE69721314T patent/DE69721314T2/de not_active Expired - Lifetime
- 1997-10-08 CZ CZ0112099A patent/CZ298402B6/cs not_active IP Right Cessation
- 1997-10-08 KR KR1019990703032A patent/KR20000048981A/ko not_active Withdrawn
- 1997-10-08 SK SK5098-2005A patent/SK285455B6/sk active Protection Beyond IP Right Term
- 1997-10-08 MA MA24828A patent/MA24370A1/fr unknown
- 1997-10-08 DK DK03008979T patent/DK1334725T3/da active
- 1997-10-08 AT AT03008979T patent/ATE353652T1/de active
- 1997-10-08 AR ARP970104638A patent/AR009113A1/es not_active Application Discontinuation
- 1997-10-08 PT PT97944940T patent/PT956022E/pt unknown
- 1997-10-08 CN CN97180380A patent/CN1239893A/zh active Pending
- 1997-10-08 CN CNA2007101694575A patent/CN101229173A/zh active Pending
- 1997-10-08 NZ NZ334876A patent/NZ334876A/xx not_active IP Right Cessation
- 1997-10-08 IL IL12919497A patent/IL129194A/xx not_active IP Right Cessation
- 1997-10-08 ID IDW990211A patent/ID21569A/id unknown
- 1997-10-08 AU AU46273/97A patent/AU745571B2/en not_active Expired
- 1997-10-08 EP EP97944940A patent/EP0956022B1/fr not_active Expired - Lifetime
- 1997-10-08 SK SK438-99A patent/SK285056B6/sk not_active IP Right Cessation
- 1997-10-08 CN CN201510024865.6A patent/CN104706641A/zh active Pending
- 1997-10-08 PL PL332610A patent/PL192979B1/pl unknown
- 1997-10-08 DZ DZ970177A patent/DZ2327A1/xx active
- 1997-10-08 CA CA2268358A patent/CA2268358C/fr not_active Expired - Lifetime
- 1997-10-08 KR KR1020067013702A patent/KR100782638B1/ko not_active Expired - Lifetime
- 1997-10-08 US US09/284,147 patent/US6831073B1/en not_active Expired - Lifetime
- 1997-10-08 AT AT97944940T patent/ATE238057T1/de active
- 1997-10-08 BR BR9712274-2A patent/BR9712274A/pt not_active Application Discontinuation
- 1997-10-08 DE DE69737373T patent/DE69737373T2/de not_active Expired - Lifetime
- 1997-10-08 PT PT03008979T patent/PT1334725E/pt unknown
- 1997-10-08 TR TR1999/00764T patent/TR199900764T2/xx unknown
- 1997-10-08 WO PCT/FR1997/001792 patent/WO1998015279A1/fr not_active Ceased
- 1997-10-08 JP JP51726398A patent/JP4883542B2/ja not_active Expired - Lifetime
- 1997-10-08 ES ES97944940T patent/ES2198006T3/es not_active Expired - Lifetime
- 1997-10-15 TW TW086115281A patent/TW491704B/zh not_active IP Right Cessation
1999
- 1999-03-31 NO NO19991593A patent/NO324357B1/no not_active IP Right Cessation
- 1999-04-08 OA OA9900078A patent/OA11033A/fr unknown
- 1999-10-25 US US09/423,108 patent/US6906049B1/en not_active Expired - Lifetime
2004
- 2004-01-08 US US10/753,073 patent/US20040220163A1/en not_active Abandoned
2007
- 2007-01-03 US US11/649,672 patent/US7749987B2/en not_active Expired - Fee Related
2009
- 2009-10-26 AR ARP090104109A patent/AR073972A2/es not_active Application Discontinuation
2011
- 2011-01-06 CL CL2011000017A patent/CL2011000017A1/es unknown
2012
- 2012-01-13 LU LU91932C patent/LU91932I2/fr unknown
- 2012-01-19 FR FR12C0005C patent/FR12C0005I2/fr active Active
- 2012-01-23 DE DE201212000010 patent/DE122012000010I1/de active Pending
- 2012-01-24 NO NO2012002C patent/NO2012002I2/no not_active IP Right Cessation
- 2012-01-26 HU HUS1200002C patent/HUS1200002I1/hu unknown
2015
- 2015-11-24 HK HK15111561.9A patent/HK1210708A1/xx unknown
2017
- 2017-08-08 NO NO2017043C patent/NO2017043I2/no unknown

Also Published As

Publication number	Publication date
AR073972A2 (es)	2010-12-15
FR12C0005I1 (fr)	2012-02-24
TR199900764T2 (xx)	1999-07-21
RU2274450C2 (ru)	2006-04-20
ATE353652T1 (de)	2007-03-15
ZA979011B (en)	1998-06-03
CN101229173A (zh)	2008-07-30
DK1334725T3 (da)	2007-06-11
ES2282539T3 (es)	2007-10-16
NO2012002I2 (no)	2013-04-02
AR009113A1 (es)	2000-03-08
KR20000048981A (ko)	2000-07-25
WO1998015279A1 (fr)	1998-04-16
DE69737373D1 (de)	2007-03-29
EP1334725B1 (fr)	2007-02-14
EP0956022B1 (fr)	2003-04-23
TNSN97164A1 (fr)	1999-12-31
FR2754179B1 (fr)	1998-12-24
DE69737373T2 (de)	2007-06-21
IL129194A (en)	2003-06-24
HK1210708A1 (en)	2016-05-06
US20040220163A1 (en)	2004-11-04
CN104706641A (zh)	2015-06-17
KR100782638B1 (ko)	2007-12-06
TW491704B (en)	2002-06-21
IL129194A0 (en)	2000-02-17
ATE238057T1 (de)	2003-05-15
AU4627397A (en)	1998-05-05
US20070281912A1 (en)	2007-12-06
DE69721314T2 (de)	2004-02-12
LU91932I9 (no)	2018-12-27
SK285056B6 (sk)	2006-05-04
SK43899A3 (en)	1999-12-10
DE122012000010I1 (de)	2012-04-19
MA24370A1 (fr)	1998-07-01
US6831073B1 (en)	2004-12-14
PT956022E (pt)	2003-07-31
NO2012002I1 (no)	2012-01-24
CN1239893A (zh)	1999-12-29
CZ9901120A3 (cs)	2000-11-15
DK0956022T3 (da)	2003-08-04
MY128482A (en)	2007-02-28
PT1334725E (pt)	2007-05-31
OA11033A (fr)	2003-03-06
PL192979B1 (pl)	2006-12-29
EP1334725A3 (fr)	2004-01-21
BR9712274A (pt)	1999-08-31
US7749987B2 (en)	2010-07-06
AP9901500A0 (en)	1999-06-30
CA2268358C (fr)	2010-04-20
YU18099A (sh)	2002-03-18
FR12C0005I2 (fr)	2016-06-24
NO991593D0 (no)	1999-03-31
PL332610A1 (en)	1999-09-27
HUP9904508A2 (hu)	2000-06-28
EP1334725A2 (fr)	2003-08-13
CA2268358A1 (fr)	1998-04-16
US6906049B1 (en)	2005-06-14
JP2002509524A (ja)	2002-03-26
NO991593L (no)	1999-06-07
KR20060084864A (ko)	2006-07-25
ID21569A (id)	1999-06-24
HU227450B1 (en)	2011-06-28
HUS1200002I1 (hu)	2016-08-29
NO324357B1 (no)	2007-10-01
DE69721314D1 (de)	2003-05-28
NO2017043I1 (no)	2017-08-08
JP4883542B2 (ja)	2012-02-22
HUP9904508A3 (en)	2001-01-29
FR2754179A1 (fr)	1998-04-10
EP0956022A1 (fr)	1999-11-17
ES2198006T3 (es)	2004-01-16
CZ298402B6 (cs)	2007-09-19
AU745571B2 (en)	2002-03-21
LU91932I2 (fr)	2012-03-13
SK285455B6 (sk)	2007-01-04
DZ2327A1 (fr)	2002-12-28
NZ334876A (en)	2001-06-29
AP1171A (en)	2003-06-30
CL2011000017A1 (es)	2011-06-24

Publication	Publication Date	Title
NO2017043I2 (no)	2019-01-25	Nomegestrolacetat + fritt eller esterifisert østradiol - forlenget SPC
DE69824508D1 (de)	2004-07-22	Fernsprechbasiertes Anweisungssystem
DE69724903D1 (de)	2003-10-23	Führungsdraht
DE69818942D1 (de)	2003-11-20	Stanolester enthaltende Zusammensetzungen
FI991091A7 (fi)	1999-06-16	Kutistettava elin
FI930063L (fi)	1993-07-11	Polyeterfosfatestrar
DE69801633D1 (de)	2001-10-18	Ester coproduktion
DE69719794D1 (de)	2003-04-17	Hangluftfahrzeug
DE69731493D1 (de)	2004-12-09	Analoger FIFO-Speicher
FI962287A7 (fi)	1996-07-26	Aspergillus foetidus ilmentämisjärjestelmä
DE59604289D1 (de)	2000-03-02	Ungesättigter Ester
KR950031573U (ko)	1995-11-22	조작전선덕트의 구조
KR930026573U (ko)	1993-12-28	버스(Bus) 덕트(Duct)용 접속구
FI955250L (fi)	1996-05-09	Johtokanava
KR970023522U (ko)	1997-06-18	노구 지금 제거 노즐 치구
DE59709469D1 (de)	2003-04-17	Wartensystem
FI940233A0 (fi)	1994-01-18	Adventkalender eller dylikt
KR960008281U (ko)	1996-03-15	버스 승차대
KR970044272U (ko)	1997-07-31	가스오븐렌지의 와이어 선반 구조
KR950025674U (ko)	1995-09-18	컴퓨터에서의 음성을 통한 안내장치
FI1304U1 (fi)	1994-04-14	Sockel foer trafikmaerke eller avstaengningsanordning
FI943896A0 (fi)	1994-08-24	Foerfarande foer maetning av egenskaperna hos pappersmassa eller papper
KR970055638U (ko)	1997-10-13	간이진압복
KR960021478U (ko)	1996-07-18	버스 손잡이용 지지대
KR970058259U (ko)	1997-11-10	선체 관통형 프로펠러